Kintor Pharmaceutical Limited (9939.HK)
HKD 1.16
(-0.85%)
HKD 1.16
(-0.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -387.58 Million | -961.26 Thousand | -1.05 Million | -380.88 Thousand | -228.04 Thousand | -114.86 Thousand |
| Net Income | -1.06 Billion | -954.36 Thousand | -842.09 Thousand | -508.3 Thousand | -232.57 Thousand | -108.48 Thousand |
| Depreciation & Amortization | 18.97 Million | 18.23 Thousand | 10.36 Thousand | 6335.00 | 4599.00 | 2439.00 |
| Deferred income taxes | - | 155.25 Thousand | 400.04 Thousand | -15.13 Thousand | - | - |
| Stock-based compensation | 22.98 Million | 95.63 Million | 37.34 Million | 28.15 Million | - | - |
| Change in working capital | -96.48 Million | -250.89 Thousand | -437.39 Thousand | -13.02 Thousand | -10.69 Thousand | -10.83 Thousand |
| Other non-cash items | -3.38 Million | -25.12 Thousand | -219.63 Thousand | 121.08 Thousand | 10.62 Thousand | 2012.00 |
| Investing Cash Flow | 3.27 Million | 67.19 Thousand | 92 Thousand | -439.72 Thousand | -7013.00 | -64.74 Thousand |
| Investments in PPE | -2.72 Million | -27.47 Thousand | -76.23 Thousand | -69.03 Thousand | -67.24 Thousand | -5249.00 |
| Acquisitions | - | -18.51 Million | -195.53 Million | 345.17 Million | -578 Thousand | 577 Thousand |
| Investment purchases | -137.09 Million | -220.7 Million | -515.4 Million | -733.69 Million | -55 Million | -221 Million |
| Sales/Maturities of investments | 136.25 Million | 337.05 Million | 710.94 Million | 388.51 Million | 55.57 Million | 241.48 Million |
| Other Investing Activities | 5.21 Million | -97.74 Million | 168.24 Thousand | -370.69 Thousand | 60.22 Thousand | -21.11 Million |
| Financing Cash Flow | -33.46 Million | 815.75 Thousand | 857.41 Thousand | 1.78 Million | 295.85 Thousand | 303.93 Thousand |
| Debt repayment | -29.4 Million | -53.01 Thousand | -112.52 Thousand | -82.3 Thousand | -67.81 Thousand | -55.98 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -40.87 Thousand | - |
| Common Stock Issuance | 755 Thousand | 698.76 Million | 951.97 Million | 1.65 Billion | - | - |
| Other Financing Activities | 737.00 | -697.89 Million | -951 Million | -1.65 Billion | 404.54 Thousand | 359.91 Thousand |
| Accounts receivables | 7623.00 | 94.23 Thousand | -86.03 Thousand | -13.02 Thousand | -10.69 Thousand | -10.83 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -376 Thousand | -345.12 Thousand | -351.36 Thousand | - | - | - |
| Other working capital | 3405.00 | 30.24 Thousand | -6162.00 | -7018.00 | -15.78 Thousand | -4941.00 |
| Cash at beginning of period | 864.47 Million | 926.33 Thousand | 1.06 Million | 195.53 Thousand | 137.51 Thousand | 13.19 Thousand |
| Cash at end of period | 444.02 Million | 864.47 Thousand | 926.33 Thousand | 1.06 Million | 195.53 Thousand | 137.51 Thousand |
| Capital Expenditure | -2.72 Million | -27.47 Thousand | -76.23 Thousand | -69.03 Thousand | -67.24 Thousand | -5249.00 |
| Effect of forex changes on cash | -2.67 Million | 16.45 Thousand | -36.41 Thousand | -90.53 Thousand | -2778.00 | -1.00 |
| Net cash flow / Change in cash | -420.44 Million | -61.86 Thousand | -138.35 Thousand | 869.15 Thousand | 58.01 Thousand | 124.32 Thousand |
| Free Cash Flow | -390.3 Million | -988.73 Thousand | -1.12 Million | -449.91 Thousand | -295.28 Thousand | -120.11 Thousand |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -848.7 Thousand | -1.06 Billion | -212.11 Thousand | -435.94 Thousand | -954.36 Thousand | -518.42 Thousand |
| Depreciation & Amortization | 9194.00 | 18.97 Million | 9663.00 | 9563.00 | 18.23 Thousand | 8674.00 |
| Deferred income taxes | - | - | - | 205.1 Thousand | 155.25 Thousand | - |
| Stock-based compensation | -11.36 Thousand | 22.98 Million | 41.78 Thousand | 45.79 Thousand | 95.63 Million | 49.84 Thousand |
| Change in working capital | 10.65 Thousand | -96.48 Million | - | -220.65 Thousand | -250.89 Thousand | - |
| Other non-cash items | 666.44 Thousand | -3.38 Million | -53.13 Thousand | 348.08 Thousand | -25.12 Thousand | -248.2 Thousand |
| Investing Cash Flow | 3036.00 | 3.27 Million | 238.00 | 25.18 Thousand | 67.19 Thousand | 42.01 Thousand |
| Investments in PPE | -2194.00 | -2.72 Million | -529.00 | -16.38 Thousand | -27.47 Thousand | -11.08 Thousand |
| Acquisitions | - | - | - | - | -18.51 Million | - |
| Investment purchases | - | -137.09 Million | - | - | -220.7 Million | - |
| Sales/Maturities of investments | - | 136.25 Million | - | - | 337.05 Million | - |
| Other Investing Activities | 5230.00 | 5.21 Million | 767.00 | 41.57 Thousand | -97.74 Million | 53.09 Thousand |
| Financing Cash Flow | -70.1 Thousand | -33.46 Million | 36.63 Thousand | 749.15 Thousand | 815.75 Thousand | 66.59 Thousand |
| Debt repayment | - | -29.4 Million | -35.99 Thousand | - | -53.01 Thousand | -65.62 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 755 Thousand | - | - | 698.76 Million | - |
| Other Financing Activities | -70.1 Thousand | 737.00 | 642.00 | 749.15 Thousand | -697.89 Million | 974.00 |
| Accounts receivables | 7623.00 | 7623.00 | - | 94.23 Thousand | 94.23 Thousand | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -376.00 | -376 Thousand | - | -345.12 Thousand | -345.12 Thousand | - |
| Other working capital | 3405.00 | 3405.00 | - | 30.24 Thousand | 30.24 Thousand | - |
| Cash at beginning of period | 690.7 Thousand | 864.47 Million | 864.47 Thousand | 337.26 Thousand | 926.33 Thousand | 926.33 Thousand |
| Cash at end of period | 444.02 Thousand | 444.02 Million | 690.7 Thousand | 864.47 Thousand | 864.47 Thousand | 337.26 Thousand |
| Capital Expenditure | -2194.00 | -2.72 Million | -529.00 | -16.38 Thousand | -27.47 Thousand | -11.08 Thousand |
| Effect of forex changes on cash | -5831.00 | -2.67 Million | 3158.00 | 6017.00 | 16.45 Thousand | 10.43 Thousand |
| Net cash flow / Change in cash | -246.68 Thousand | -420.44 Million | -173.76 Thousand | 527.2 Thousand | -61.86 Thousand | -589.06 Thousand |
| Free Cash Flow | -175.97 Thousand | -390.3 Million | -214.32 Thousand | -269.54 Thousand | -988.73 Thousand | -719.18 Thousand |
NWI
ALIZY
0LWH
0035
5857
GLABF